| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A catalog of curated breast cancer genes
|
Bose, Muthiah
|
|
|
191 |
2 |
p. 431-441
|
artikel
|
| 2 |
Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
|
Wilson, Brooke E.
|
|
|
191 |
2 |
p. 257-267
|
artikel
|
| 3 |
Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study
|
Wu, Zhen-Yu
|
|
|
191 |
2 |
p. 365-373
|
artikel
|
| 4 |
Classes of therapeutics to amplify the immune response
|
Hu, Yang
|
|
|
191 |
2 |
p. 277-289
|
artikel
|
| 5 |
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)
|
Jank, Paul
|
|
|
191 |
2 |
p. 327-333
|
artikel
|
| 6 |
Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer
|
Ho, Alice Y.
|
|
|
191 |
2 |
p. 229-241
|
artikel
|
| 7 |
Dietary supplement use and documentation in a breast cancer survivorship clinic
|
Silver, Julia
|
|
|
191 |
2 |
p. 385-388
|
artikel
|
| 8 |
Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?
|
Rosier, Luderve
|
|
|
191 |
2 |
p. 375-383
|
artikel
|
| 9 |
Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody–drug conjugates and bispecific antibodies
|
Torres, Evanthia T. Roussos
|
|
|
191 |
2 |
p. 291-302
|
artikel
|
| 10 |
Emerging immunotherapeutic strategies for the treatment of breast cancer
|
Huppert, Laura A.
|
|
|
191 |
2 |
p. 243-255
|
artikel
|
| 11 |
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
|
Schreiber, Anna R.
|
|
|
191 |
2 |
p. 389-399
|
artikel
|
| 12 |
Exclusion criteria of breast cancer clinical trial protocols: a descriptive analysis
|
Wan, Clara
|
|
|
191 |
2 |
p. 471-475
|
artikel
|
| 13 |
Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
|
Honkanen, Tiia J.
|
|
|
191 |
2 |
p. 443-450
|
artikel
|
| 14 |
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
|
Small, Brent J.
|
|
|
191 |
2 |
p. 459-469
|
artikel
|
| 15 |
Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study
|
Barni, Sandro
|
|
|
191 |
2 |
p. 477-480
|
artikel
|
| 16 |
Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer
|
Rothschild, Harriet T.
|
|
|
191 |
2 |
p. 451-458
|
artikel
|
| 17 |
Oncologic outcomes of immediate breast reconstruction in young women with breast cancer receiving neoadjuvant chemotherapy
|
Wu, Zhen-Yu
|
|
|
191 |
2 |
p. 345-354
|
artikel
|
| 18 |
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer
|
Nyrop, K. A.
|
|
|
191 |
2 |
p. 409-422
|
artikel
|
| 19 |
qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer
|
Zuo, Ke
|
|
|
191 |
2 |
p. 335-344
|
artikel
|
| 20 |
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective study
|
Klinger, Marco
|
|
|
191 |
2 |
p. 355-363
|
artikel
|
| 21 |
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis
|
Poggio, Francesca
|
|
|
191 |
2 |
p. 269-275
|
artikel
|
| 22 |
Supervised machine learning model to predict oncotype DX risk category in patients over age 50
|
Pawloski, Kate R.
|
|
|
191 |
2 |
p. 423-430
|
artikel
|
| 23 |
The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
|
Jenkins, J. Asher
|
|
|
191 |
2 |
p. 401-407
|
artikel
|
| 24 |
Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics
|
Lewis Phillips, Gail
|
|
|
191 |
2 |
p. 303-317
|
artikel
|
| 25 |
Upregulation of estrogen receptor alpha (ERα) expression in transgenic mice expressing human CYP4Z1
|
Khayeka-Wandabwa, Christopher
|
|
|
191 |
2 |
p. 319-326
|
artikel
|
Tijdschrift beschrijving